ALBUQUERQUE, N.M.--(BUSINESS WIRE)--Feb. 27, 2004--Indesign (Indianapolis, Ind.) has been retained by Advanced Optics Electronics Inc. (OTC BB: ADOT - News) to increase the capabilities of ADOT's advanced sign development technology. Focus on enhancement will be directed to light sensitivity and video synchronicity.
Biomoda Inc. (30% directly and indirectly held by ADOT) has filed an additional patent relating to assay and protocol tests. Biomoda's pending SB-2 is slated for completion shortly after the company files its 10K for 2003.

Advanced Optics Electronics Inc.'s 2003 10K is scheduled to be filed within the next 30 days. The company recently confirmed that outstanding debt continues to be greatly reduced. Net worth will reflect this fact and other positive developments.

Advanced Optics currently holds approximately 16% of Biomoda Inc. as a direct investment and over 20%(a) of Genomed Inc., a publicly traded biotech company. A review has been commissioned and is now underway to determine the direction of a proposed joint venture in the near future involving both entities.

(a) 14.2% as of 2/27/04; 20.3% after 3/15/04
Advanced Optics Electronics Inc. is a technology company based in Albuquerque, N.M. The company maintains an R&D facility and manufacturing plant, and is engaged in building large-scale flat panel displays utilizing its patented and patent pending technology.

In addition to the core business of ADOT, the company has made a strategic technology-oriented investment in Biomoda Inc. Biomoda Inc. is a company that holds patents and patents pending domestically and internationally for the early detection of lung cancer. ADOT currently holds directly and indirectly 30% of Biomoda Inc.

This news release contains forward-looking statements that involve a high degree of risk and uncertainty. Such statements include, but are not limited to, statements containing the words "believes," "anticipates," "expects," "estimates" and words of similar import. The company's actual results could differ materially from any forward-looking statements, which reflect management's opinions only as of the date of this report, as a result of risks and uncertainties that exist in our operation, development efforts and business environment. The company undertakes no obligation to revise or publicly release the results of any revisions to these forward-looking statements. You should carefully review the risk factors in other documents that the company files from time to time with the Securities and Exchange Commission, including its Quarterly Reports on Form 10-Q.